Literature DB >> 33708210

IL-10 Enhances Human Natural Killer Cell Effector Functions via Metabolic Reprogramming Regulated by mTORC1 Signaling.

Zixi Wang1,2, Di Guan2,3, Jianxin Huo2,4, Subhra K Biswas4, Yuhan Huang4, Yuansheng Yang2, Shengli Xu2,4,5, Kong-Peng Lam1,2,4.   

Abstract

Cell metabolism plays a pivotal role in regulating the effector functions of immune cells. Stimulatory cytokines, such as interleukin (IL)-2 or IL-12 and IL-15, activate glycolysis and oxidative phosphorylation in natural killer (NK) cells to support their enhanced effector functions. IL-10, a pleiotropic cytokine, is known to suppress macrophage activation but stimulate NK cells. However, it remains unclear if IL-10 has an effect on the metabolism of human NK cells and if so, what metabolic mechanisms are affected, and how these metabolic changes are regulated and contribute to the effector functions of NK cells. In this study, we demonstrate that IL-10 upregulates both glycolysis and oxidative phosphorylation in human NK cells, and these metabolic changes are crucial for the enhanced effector functions of NK cells. Mechanistically, we unravel that IL-10 activates the mammalian target of rapamycin complex 1 (mTORC1) to regulate metabolic reprogramming in human NK cells.
Copyright © 2021 Wang, Guan, Huo, Biswas, Huang, Yang, Xu and Lam.

Entities:  

Keywords:  IFN-γ; IL-10; NK cell; cytotoxicity; mTOR; metabolism

Mesh:

Substances:

Year:  2021        PMID: 33708210      PMCID: PMC7940510          DOI: 10.3389/fimmu.2021.619195

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  44 in total

1.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  Human cytomegalovirus IL-10 augments NK cell cytotoxicity.

Authors:  Kayla A Holder; Michael D Grant
Journal:  J Leukoc Biol       Date:  2019-04-09       Impact factor: 4.962

3.  Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis.

Authors:  N Kundu; A M Fulton
Journal:  Cell Immunol       Date:  1997-08-25       Impact factor: 4.868

Review 4.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

5.  Serum levels of interleukin 10 (IL-10) in patients with type 2 diabetes.

Authors:  N Yaghini; M Mahmoodi; Gh R Asadikaram; Gh H Hassanshahi; H Khoramdelazad; M Kazemi Arababadi
Journal:  Iran Red Crescent Med J       Date:  2011-10-01       Impact factor: 0.611

6.  IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells.

Authors:  Ju Yeong Park; Suk Hyung Lee; Suk-Ran Yoon; Young-Jun Park; Haiyoung Jung; Tae-Don Kim; Inpyo Choi
Journal:  Mol Cells       Date:  2011-07-29       Impact factor: 5.034

7.  Activation-specific metabolic requirements for NK Cell IFN-γ production.

Authors:  Molly P Keppel; Nermina Saucier; Annelise Y Mah; Tiphanie P Vogel; Megan A Cooper
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

8.  IL-10 elicits IFNγ-dependent tumor immune surveillance.

Authors:  John B Mumm; Jan Emmerich; Xueqing Zhang; Ivan Chan; Lingling Wu; Smita Mauze; Steven Blaisdell; Beth Basham; Jie Dai; Jeff Grein; Catherine Sheppard; Kyu Hong; Collette Cutler; Scott Turner; Drake LaFace; Melanie Kleinschek; Michael Judo; Gulesi Ayanoglu; John Langowski; Danling Gu; Brittany Paporello; Erin Murphy; Venkataraman Sriram; Saraswathi Naravula; Bela Desai; Satya Medicherla; Wolfgang Seghezzi; Terrill McClanahan; Susan Cannon-Carlson; Amy M Beebe; Martin Oft
Journal:  Cancer Cell       Date:  2011-12-13       Impact factor: 31.743

9.  Fas apoptosis inhibitory molecule is upregulated by IGF-1 signaling and modulates Akt activation and IRF4 expression in multiple myeloma.

Authors:  J Huo; S Xu; B Lin; W-J Chng; K-P Lam
Journal:  Leukemia       Date:  2012-11-09       Impact factor: 11.528

Review 10.  T(H)1 cells control themselves by producing interleukin-10.

Authors:  Anne O'Garra; Paulo Vieira
Journal:  Nat Rev Immunol       Date:  2007-06       Impact factor: 53.106

View more
  8 in total

1.  Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response.

Authors:  Robert B Rebhun; Daniel York; Sylvia Margret Cruz; Sean J Judge; Aryana M Razmara; Lauren E Farley; Rachel V Brady; Eric G Johnson; Jenna H Burton; Jennifer Willcox; Luke A Wittenburg; Kevin Woolard; Cordelia Dunai; Susan L Stewart; Ellen E Sparger; Sita S Withers; Alicia A Gingrich; Katherine A Skorupski; Sami Al-Nadaf; Amandine T LeJeune; William Tn Culp; William J Murphy; Michael S Kent; Robert J Canter
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 2.  Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer.

Authors:  Éilis Russell; Melissa J Conroy; Martin P Barr
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

Review 3.  The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis.

Authors:  Zhihua Ren; Yueru Yu; Chaoxi Chen; Dingyong Yang; Ting Ding; Ling Zhu; Junliang Deng; Zhiwen Xu
Journal:  Front Microbiol       Date:  2021-11-30       Impact factor: 5.640

4.  Adenosine A2A Receptor Suppressed Astrocyte-Mediated Inflammation Through the Inhibition of STAT3/YKL-40 Axis in Mice With Chronic Cerebral Hypoperfusion-induced White Matter Lesions.

Authors:  Jichao Yuan; Lin Chen; Jie Wang; Simin Xia; Jialu Huang; Linke Zhou; Chengjian Feng; Xiaofei Hu; Zhenhua Zhou; Hong Ran
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

5.  Pro- and Anti-Inflammatory Cytokines in the Context of NK Cell-Trophoblast Interactions.

Authors:  Valentina Mikhailova; Polina Grebenkina; Evgeniia Khokhlova; Alina Davydova; Zeina Salloum; Elizaveta Tyshchuk; Valeria Zagainova; Kseniia Markova; Igor Kogan; Sergey Selkov; Dmitry Sokolov
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

6.  The mTORC1 Signaling Support Cellular Metabolism to Dictate Decidual NK Cells Function in Early Pregnancy.

Authors:  Song Yan; Jie Dong; Chenxi Qian; Shuqiang Chen; Qian Xu; Hui Lei; Xiaohong Wang
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

7.  Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling.

Authors:  Noha M Elemam; Sarah Hammoudeh; Laila Salameh; Bassam Mahboub; Habiba Alsafar; Iman M Talaat; Peter Habib; Mehmood Siddiqui; Khalid Omar Hassan; Omar Yousef Al-Assaf; Jalal Taneera; Nabil Sulaiman; Rifat Hamoudi; Azzam A Maghazachi; Qutayba Hamid; Maha Saber-Ayad
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

Review 8.  Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity.

Authors:  Alberto Mendoza-Valderrey; Maite Alvarez; Andrea De Maria; Kim Margolin; Ignacio Melero; Maria Libera Ascierto
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.